PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954597
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954597
The global dental bone graft substitutes market was valued at USD 328.14 million in 2025 and is projected to grow to USD 350.25 million in 2026. The market is expected to reach USD 612.03 million by 2034, exhibiting a CAGR of 7.23% during the forecast period (2026-2034).
North America dominated the global market with a 47.93% share in 2025, driven by a high number of dental implant procedures, rising cases of bone injuries, and strong product innovation.
Dental bone graft substitutes are natural or synthetic materials used to repair or regenerate damaged bone tissue in dental procedures. These products include allografts, synthetic bone substitutes, demineralized bone matrix (DBM), and xenografts, and are widely used in implant dentistry and periodontal treatments.
Market Overview & Growth Drivers
The rising prevalence of dental disorders is a key factor driving market growth. According to the World Health Organization (WHO), 514 million children suffer from primary tooth decay, while 2 million adults are affected by permanent tooth decay globally. Increasing cases of periodontal disease, dental fractures, and tooth loss have accelerated demand for dental implants, thereby increasing the need for bone graft substitutes.
Additionally, the introduction of advanced products, growing awareness among patients, and increased R&D investments are contributing to market expansion. Strategic collaborations, acquisitions, and funding initiatives are further supporting innovation and product adoption.
Although the market declined in 2020 due to COVID-19-related clinic closures and restricted procedures, recovery began in 2021 with reopening of dental practices, increasing tele-dentistry adoption, and rising implant surgeries. The positive growth trend is expected to continue through 2034.
Market Trends
Rise of 3D-Printed Synthetic Bone Grafts
One of the most significant trends is the adoption of 3D-printed synthetic bone graft substitutes. These grafts closely mimic natural bone structure and enable better integration and long-term outcomes. Technological advancements allow customized graft design tailored to individual patients.
For example, in December 2022, Desktop Metal received U.S. FDA approval for its CMFlex 3D-printed regenerative bone graft for dental use. Increasing regulatory approvals and technological innovations are expected to further strengthen this trend.
Market Growth Factors
Introduction of Advanced Bone Graft Substitutes
The growing number of dental implant procedures requiring jawbone stabilization has increased demand for innovative graft materials.
Such developments are expected to accelerate product adoption globally.
Strategic Acquisitions & Partnerships
Acquisitions and collaborations are strengthening market penetration. For instance, Biocomposites acquired Artoss in June 2023, expanding its bone graft portfolio in dentistry. Partnerships between manufacturers and dental service organizations (DSOs) are also boosting accessibility and product distribution.
Restraining Factors
Despite strong growth prospects, challenges remain. Clinical limitations, concerns about disease transmission, immunogenicity, inadequate bone formation, and strict regulatory requirements can limit adoption. Additionally, limited reimbursement coverage in several countries increases out-of-pocket expenses for patients, potentially restricting demand.
By Product Type
The market is segmented into allografts, synthetic substitutes, demineralized bone matrix, and xenografts.
By Form
The market includes granules, putty, and others.
By End-User
The market is segmented into solo practices, DSO/group practices, and others.
North America
North America recorded USD 156.88 million in 2025 and is projected to reach USD 167.86 million in 2026. The U.S. market alone is expected to reach USD 152.04 million in 2026. Strong innovation, FDA approvals, and high implant volumes support growth.
Europe
Europe held the second-largest market share.
Strategic acquisitions and R&D investments are driving expansion.
Asia Pacific
Asia Pacific is projected to register the highest CAGR.
Growth is fueled by rising geriatric population and increasing dental disorder prevalence.
Latin America & Middle East & Africa
Growth in these regions is driven by improving healthcare infrastructure, growing awareness, and increasing medical tourism.
Competitive Landscape
Key players include ZimVie Inc., Medtronic, Geistlich Pharma AG, Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, NovaBone, BioHorizons, botiss biomaterials GmbH, and others.
These companies focus on R&D, product launches, acquisitions, and geographical expansion to strengthen their market positions.
Conclusion
The global dental bone graft substitutes market is poised for steady growth, expanding from USD 328.14 million in 2025 to USD 612.03 million by 2034, driven by increasing dental implant procedures, technological advancements such as 3D-printed grafts, and strong regional innovation. North America remains the dominant market, while Asia Pacific is emerging as the fastest-growing region. Despite reimbursement and clinical challenges, rising R&D investments and strategic collaborations are expected to ensure sustained market expansion through 2034.
Segmentation By Product Type
By Form
By End-user
By Regin